Unitedhealth Group INC Form 4 insider transactions

Director Timothy Flynn of UnitedHealth Group reported acquiring shares and dividend equivalents, while also transferring shares from a trust.

UnitedHealth Group director Valerie Montgomery Rice acquired 24 shares of common stock through dividend equivalents on vested deferred stock units.

A UnitedHealth Group director, Michele J. Hooper, acquired 157 shares of common stock through dividend equivalents on vested deferred stock units.

Director Kristen Gil of UnitedHealth Group acquired 4 shares of common stock through dividend equivalents, increasing her indirect holdings.

Director Paul R. Garcia of UnitedHealth Group reported the acquisition of 6 shares of common stock and adjustments to holdings in various trusts.

Frederick William McNabb III, a director at UnitedHealth Group, acquired 30 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group's President and CFO, John F. Rex, disposed of 314.585 shares of common stock on November 13, 2024.

Director Stephen J. Hemsley of UnitedHealth Group reported a gift transfer of 8,000 common shares on November 11, 2024.

Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, sold 701 shares of common stock on November 11, 2024.

Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reports the disposal of common stock to cover tax obligations.

Director John H. Noseworthy acquired 161 shares of UnitedHealth Group common stock as part of a deferred stock unit compensation plan.

Director Timothy Flynn reports acquisition of 161 shares of UnitedHealth Group common stock and indirect ownership of 2,000 shares via trust.

Director Charles D. Baker reported the acquisition of 151 shares of UnitedHealth Group common stock on October 1, 2024, as part of director compensation.

Director Michele J. Hooper reports acquiring 97 deferred stock units of UnitedHealth Group as part of regular quarterly compensation.

Director Paul R. Garcia reports acquisition of UnitedHealth Group common stock and deferred stock units as part of regular quarterly compensation.

Stephen J. Hemsley, a director at UnitedHealth Group, reported acquiring 245 shares of common stock on October 1, 2024, as part of regular quarterly compensation.

Director Frederick William McNabb III acquired 164 shares of UnitedHealth Group common stock as part of his quarterly compensation.

Director Kristen Gil reports acquisition of UnitedHealth Group stock and deferred stock units as part of regular quarterly compensation.

Director Valerie Montgomery Rice acquired 161 deferred stock units of UnitedHealth Group on October 1, 2024, as part of her quarterly compensation for board service.

Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition and disposal of UnitedHealth Group common stock due to dividend equivalents on restricted stock units.

Director Michele J. Hooper reported the acquisition of 132 shares of UnitedHealth Group common stock due to dividend equivalents.

EVP & Chief Legal Officer of UnitedHealth Group, Christopher R. Zaetta, reports acquisition of common stock due to dividend equivalents paid on restricted stock units.

Director Frederick William McNabb III acquired 25 shares of UnitedHealth Group common stock through dividend equivalents on vested deferred stock units.

Director Charles D. Baker reports acquiring 2 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

Director Kristen Gil reports acquisition of UnitedHealth Group common stock and dividend equivalents through direct and indirect ownership.

Director Paul R. Garcia reports acquisition of UnitedHealth Group common stock due to dividend equivalents.

John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and dividend equivalents.

Stephen J. Hemsley, a director at UnitedHealth Group, reports acquisition of common stock and dividend equivalents.

John H. Noseworthy, a director at UnitedHealth Group, acquired 19 shares of common stock through dividend equivalents on vested deferred stock units.

Brian Thompson, CEO of UnitedHealthcare, reports the acquisition of common stock and dividend equivalents related to restricted stock units.